Our Mission

To reduce cancer burden through innovative, epidemiologic research.

Research Projects

The CHALLENGE Trial

Dr. Friedenreich

The Colon Health and Life Long Exercise Trial (CHALLENGE Trial) is a multi-centre randomized controlled exercise intervention trial that is funded and coordinated by the Cancer Clinical Trials Group at Queen’s University, Kingston. Dr. Friedenreich is a co-investigator on this first ever trial that is enrolling and randomizing 962 Stage II and III colon cancer…

The Breast Cancer and Exercise Trial in Alberta (BETA Trial)

Dr. Friedenreich

The Breast Cancer and Exercise Trial in Alberta (BETA) is a randomized controlled exercise intervention trial. Dr. Friedenreich and her colleagues recruited 400 postmenopausal women aged 50-74 years of age to examine how a one-year high volume (300 minutes per week) versus moderate volume (150 minutes per week) aerobic exercise intervention influences and modifies biomarkers for breast cancer risk …

Antineoplastic drugs: policy levers and opportunities for occupational exposure reduction

Dr. Peters and Dr. Brenner

Antineoplastic drugs, also known as cytotoxic or hazardous drugs, are necessary tools in cancer treatment. However, many antineoplastic drugs can also cause cancer later in life…

The Department of Cancer Epidemiology and Prevention Research

Since 2001, the scientists of CEPR have been combining traditional epidemiologic study designs with a molecular epidemiologic emphasis. The collection of demographic, lifestyle, and clinical information has now been expanded to include genetic, cellular, biomarker and metabolomic information from collected biological specimens.

Latest News

Events

There are no upcoming events.

Please send us an email if you’d like more information about upcoming events.

Follow AHS-CancerCare on Twitter

Do You Have Questions?

Send us an email and we will be in touch with you shorty. If you’d like your email directed to one of our Research Scientists, please address the message to them and it will be forwarded.